Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia.

Anemia, Sickle Cell / complications Case-Control Studies Humans Leukocytosis Retrospective Studies Risk Factors Venous Thromboembolism / etiology
Leukocytosis neutrophilia predictors sickle cell disease venous thromboembolism (VTE)

Journal

Hemoglobin
ISSN: 1532-432X
Titre abrégé: Hemoglobin
Pays: England
ID NLM: 7705865

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 17 2 2021
medline: 18 12 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

Venous thromboembolism (VTE) in individuals with sickle cell disease is common and portends a poor prognosis. The role of leukocyte count and its subsets on risk of VTE in sickle cell disease are not known. We conducted a retrospective case-control study and analyzed for leukocyte count at the time of VTE and 3 months prior. Leukocyte and neutrophil counts were elevated at the time of VTE (

Identifiants

DOI: 10.1080/03630269.2020.1869565 PMID: 33588667 PMC: PMC8842825
pubmed: 33588667
doi: 10.1080/03630269.2020.1869565
pmc: PMC8842825
mid: NIHMS1769242
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-59

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL142647
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK060445
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK083266
Pays : United States

Références

Nat Med. 2010 Aug;16(8):887-96
pubmed: 20676107
Blood. 2012 Oct 4;120(14):2879-88
pubmed: 22833547
J Thromb Haemost. 2017 Jul;15(7):1307-1316
pubmed: 28671346
Br J Haematol. 2003 Oct;123(2):359-65
pubmed: 14531921
Am J Med. 2013 May;126(5):443-9
pubmed: 23582935
Br J Haematol. 2012 May;157(3):370-80
pubmed: 22360627
Nat Med. 2017 Mar 7;23(3):279-287
pubmed: 28267716
Blood. 1998 Jun 1;91(11):4216-23
pubmed: 9596669
Immunity. 2019 Jun 18;50(6):1401-1411.e4
pubmed: 31076358
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Blood. 2012 Jul 19;120(3):636-46
pubmed: 22661702
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3047-51
pubmed: 11880644
Blood. 2016 Mar 10;127(10):1371-3
pubmed: 26817955
Br J Haematol. 2017 Jul;178(2):319-326
pubmed: 28369826
Blood. 2014 Jun 12;123(24):3818-27
pubmed: 24620350

Auteurs

Jahnavi Gollamudi (J)

Division of Hematology/Oncology, Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.

Shashank Sarvepalli (S)

Division of Gastroenterology, Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.

Animesh Vadaparti Binf (A)

Department of Integrative Biology, Guelph University, Guelph, ON, Canada.

Tara Alin (T)

Division of Hematology and UNC Blood Research Center, Department of Internal Medicine, University of North Carolina, NC, USA.

Jane A Little (JA)

Division of Hematology and UNC Blood Research Center, Department of Internal Medicine, University of North Carolina, NC, USA.

Lalitha Nayak (L)

Division of Hematology/Oncology, Department of Internal Medicine, Seidman Cancer Center, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Hémoglobinopathies › Drépanocytose › Venous Thromboembolism in Sickle Cell Disease...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › Venous Thromboembolism in Sickle Cell Disease...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Venous Thromboembolism in Sickle Cell Disease...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Hyperleucocytose › Venous Thromboembolism in Sickle Cell Disease...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Venous Thromboembolism in Sickle Cell Disease...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Venous Thromboembolism in Sickle Cell Disease...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Embolie et thrombose › Thromboembolie › Thromboembolisme veineux › Venous Thromboembolism in Sickle Cell Disease...